BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35682723)

  • 1. Angiotensin II Inhibits Insulin Receptor Signaling in Adipose Cells.
    Gutierrez-Rodelo C; Arellano-Plancarte A; Hernandez-Aranda J; Landa-Galvan HV; Parra-Mercado GK; Moreno-Licona NJ; Hernandez-Gonzalez KD; Catt KJ; Villalobos-Molina R; Olivares-Reyes JA
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682723
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
    Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
    Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiotensin-induced EGF receptor transactivation inhibits insulin signaling in C9 hepatic cells.
    Arellano-Plancarte A; Hernandez-Aranda J; Catt KJ; Olivares-Reyes JA
    Biochem Pharmacol; 2010 Mar; 79(5):733-45. PubMed ID: 19879250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiotensin-(1 7) stimulates the phosphorylation of JAK2, IRS-1 and Akt in rat heart in vivo: role of the AT1 and Mas receptors.
    Giani JF; Gironacci MM; Muñoz MC; Peña C; Turyn D; Dominici FP
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1154-63. PubMed ID: 17496209
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II inhibits insulin-stimulated GLUT4 translocation and Akt activation through tyrosine nitration-dependent mechanisms.
    Csibi A; Communi D; Müller N; Bottari SP
    PLoS One; 2010 Apr; 5(4):e10070. PubMed ID: 20383279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin-induced Akt activation is inhibited by angiotensin II in the vasculature through protein kinase C-alpha.
    Motley ED; Eguchi K; Gardner C; Hicks AL; Reynolds CM; Frank GD; Mifune M; Ohba M; Eguchi S
    Hypertension; 2003 Mar; 41(3 Pt 2):775-80. PubMed ID: 12623995
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of the mammalian target of rapamycin pathway acutely inhibits insulin signaling to Akt and glucose transport in 3T3-L1 and human adipocytes.
    Tremblay F; Gagnon A; Veilleux A; Sorisky A; Marette A
    Endocrinology; 2005 Mar; 146(3):1328-37. PubMed ID: 15576463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valsartan Alleviates Insulin Resistance in Skeletal Muscle of Chronic Renal Failure Rats.
    Wang Y; Wei RB; Yang Y; Su TY; Huang MJ; Li P; Chen XM
    Med Sci Monit; 2018 Apr; 24():2413-2419. PubMed ID: 29679000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular smooth muscle insulin resistance, but not hypertrophic signaling, is independent of angiotensin II-induced IRS-1 phosphorylation by JNK.
    Hitomi H; Mehta PK; Taniyama Y; Lassègue B; Seidel-Rogol B; San Martin A; Griendling KK
    Am J Physiol Cell Physiol; 2011 Dec; 301(6):C1415-22. PubMed ID: 21900690
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes.
    Sanni SJ; Lyngsø C; Gammeltoft S; Hansen JL
    Basic Clin Pharmacol Toxicol; 2018 May; 122(5):460-469. PubMed ID: 29136335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin II inhibits insulin-induced actin stress fiber formation and glucose uptake via ERK1/2.
    Nazari H; Takahashi A; Harada N; Mawatari K; Nakano M; Kishi K; Ebina Y; Nakaya Y
    J Med Invest; 2007 Feb; 54(1-2):19-27. PubMed ID: 17380010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II enhances insulin sensitivity in vitro and in vivo.
    Juan CC; Chien Y; Wu LY; Yang WM; Chang CL; Lai YH; Ho PH; Kwok CF; Ho LT
    Endocrinology; 2005 May; 146(5):2246-54. PubMed ID: 15705782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling-3 Provides a novel interface in the cross-talk between angiotensin II and insulin signaling systems.
    Calegari VC; Alves M; Picardi PK; Inoue RY; Franchini KG; Saad MJ; Velloso LA
    Endocrinology; 2005 Feb; 146(2):579-88. PubMed ID: 15514089
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Over-expression of NYGGF4 inhibits glucose transport in 3T3-L1 adipocytes via attenuated phosphorylation of IRS-1 and Akt.
    Zhang CM; Chen XH; Wang B; Liu F; Chi X; Tong ML; Ni YH; Chen RH; Guo XR
    Acta Pharmacol Sin; 2009 Jan; 30(1):120-4. PubMed ID: 19079291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.
    Ugi S; Imamura T; Maegawa H; Egawa K; Yoshizaki T; Shi K; Obata T; Ebina Y; Kashiwagi A; Olefsky JM
    Mol Cell Biol; 2004 Oct; 24(19):8778-89. PubMed ID: 15367694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-1alpha inhibits insulin signaling with phosphorylating insulin receptor substrate-1 on serine residues in 3T3-L1 adipocytes.
    He J; Usui I; Ishizuka K; Kanatani Y; Hiratani K; Iwata M; Bukhari A; Haruta T; Sasaoka T; Kobayashi M
    Mol Endocrinol; 2006 Jan; 20(1):114-24. PubMed ID: 16150868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic endothelin-1 treatment leads to heterologous desensitization of insulin signaling in 3T3-L1 adipocytes.
    Ishibashi KI; Imamura T; Sharma PM; Huang J; Ugi S; Olefsky JM
    J Clin Invest; 2001 May; 107(9):1193-202. PubMed ID: 11342583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Growth hormone inhibition of glucose uptake in adipocytes occurs without affecting GLUT4 translocation through an insulin receptor substrate-2-phosphatidylinositol 3-kinase-dependent pathway.
    Sasaki-Suzuki N; Arai K; Ogata T; Kasahara K; Sakoda H; Chida K; Asano T; Pessin JE; Hakuno F; Takahashi S
    J Biol Chem; 2009 Mar; 284(10):6061-70. PubMed ID: 19122000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ANG-(1-7) reduces ANG II-induced insulin resistance by enhancing Akt phosphorylation via a Mas receptor-dependent mechanism in rat skeletal muscle.
    Prasannarong M; Santos FR; Henriksen EJ
    Biochem Biophys Res Commun; 2012 Sep; 426(3):369-73. PubMed ID: 22960175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic inhibition of the mTORC1/S6K1 pathway increases insulin-induced PI3K activity but inhibits Akt2 and glucose transport stimulation in 3T3-L1 adipocytes.
    Veilleux A; Houde VP; Bellmann K; Marette A
    Mol Endocrinol; 2010 Apr; 24(4):766-78. PubMed ID: 20203102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.